Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity
暂无分享,去创建一个
J. Goudsmit | W. Keulen | B. Klaver | J Goudsmit | W Keulen | M Tersmette | A de Ronde | J J de Jong | B Klaver | W Krone | J. D. de Jong | M. Tersmette | A. D. Ronde | W. Krone | A. De ronde | J. Goudsmit | J. Jong
[1] P. Earl,et al. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity , 1988, Journal of virology.
[2] M. Akutsu,et al. Host range mutant of human immunodeficiency virus type 1: modification of cell tropism by a single point mutation at the neutralization epitope in the env gene , 1991, Journal of virology.
[3] L. van der Hoek,et al. Immunodominance and antigenic variation of the principal neutralization domain of HIV-1. , 1991, Virology.
[4] M. Emerman,et al. Effects of mutations in hyperconserved regions of the extracellular glycoprotein of human immunodeficiency virus type 1 on receptor binding , 1989, Journal of virology.
[5] S. Matsushita,et al. Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope , 1988, Journal of virology.
[6] A J Langlois,et al. Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[7] L. Arthur,et al. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[8] Peter D. Kwong,et al. Crystal structure of an HIV-binding recombinant fragment of human CD4 , 1990, Nature.
[9] W. Blattner,et al. C-terminal fragments of gp120 and synthetic peptides from five HTLV-III strains: prevalence of antibodies to the HTLV-III-MN isolate in infected individuals. , 1990, AIDS research and human retroviruses.
[10] A J Langlois,et al. Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[11] Reed J. Harris,et al. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. , 1990, The Journal of biological chemistry.
[12] G. Nakamura,et al. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor , 1987, Cell.
[13] M. Salimans,et al. Rapid and simple method for purification of nucleic acids , 1990, Journal of clinical microbiology.
[14] J. Goudsmit,et al. Numbers of CD4+ cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men. , 1988, The Journal of infectious diseases.
[15] Q. Sattentau,et al. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding , 1991, The Journal of experimental medicine.
[16] R. Schooley,et al. Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins , 1987, Journal of virology.
[17] C. Debouck,et al. Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[18] J. Sodroski,et al. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. , 1987, Science.
[19] B. Seed,et al. A CD4 domain important for HIV-mediated syncytium formation lies outside the virus binding site , 1990, Cell.
[20] M. Reitz,et al. Envelope sequences of two new United States HIV-1 isolates. , 1988, Virology.
[21] E. Freed,et al. Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain , 1991, Journal of virology.
[22] J. Berzofsky,et al. Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals. , 1991, Journal of immunology.
[23] R. Weiss,et al. Neutralizing monoclonal antibodies to the AIDS virus. , 1988, AIDS.
[24] Hans Wolf,et al. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS , 1986, Cell.
[25] Lange,et al. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates , 1989, Journal of virology.
[26] J. Davide,et al. Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. , 1990, Science.
[27] W. O'brien,et al. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain , 1990, Nature.
[28] L. Callahan,et al. Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions , 1991, Journal of virology.
[29] M. Gurney,et al. Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization. , 1988, Science.
[30] S. Matsushita,et al. Generation of neutralization-resistant HIV-1 in vitro due to amino acid interchanges of third hypervariable env region. , 1990, Journal of immunology.
[31] A. Profy,et al. Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1 , 1990, Science.
[32] C. DeLisi,et al. An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[33] M. Salimans,et al. RapidandSimple MethodforPurification ofNucleic Acids , 1990 .
[34] G. Shaw,et al. Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. , 1984, Science.
[35] R. Redfield,et al. Type-restricted neutralization of molecular clones of human immunodeficiency virus. , 1988, Science.